Wellell Inc - Asset Resilience Ratio
Wellell Inc (4106) has an Asset Resilience Ratio of 2.43% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Wellell Inc current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2002–2024)
This chart shows how Wellell Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Wellell Inc asset portfolio.
Liquid Assets Composition Over Time
This chart breaks down Wellell Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Wellell Inc long-term investment allocation to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 0% |
| Short-term Investments | NT$77.17 Million | 2.43% |
| Total Liquid Assets | NT$77.17 Million | 2.43% |
Asset Resilience Insights
- Limited Liquidity: Wellell Inc maintains only 2.43% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Wellell Inc Industry Peers by Asset Resilience Ratio
Compare Wellell Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Medtronic plc
SA:MDTC34 |
Medical Devices | 7.82% |
|
Demant A/S
CO:DEMANT |
Medical Devices | -2.59% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 34.37% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Theradiag SA
PA:ALTHE |
Medical Devices | 15.59% |
|
Biosynex
PA:ALBIO |
Medical Devices | 3.35% |
Annual Asset Resilience Ratio for Wellell Inc (2002–2024)
The table below shows the annual Asset Resilience Ratio data for Wellell Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 4.19% | NT$131.33 Million ≈ $4.14 Million |
NT$3.14 Billion ≈ $98.86 Million |
+0.75pp |
| 2023-12-31 | 3.44% | NT$110.93 Million ≈ $3.49 Million |
NT$3.22 Billion ≈ $101.60 Million |
+0.15pp |
| 2022-12-31 | 3.29% | NT$105.16 Million ≈ $3.31 Million |
NT$3.20 Billion ≈ $100.74 Million |
-0.07pp |
| 2021-12-31 | 3.36% | NT$105.59 Million ≈ $3.33 Million |
NT$3.14 Billion ≈ $98.94 Million |
-1.67pp |
| 2020-12-31 | 5.03% | NT$153.30 Million ≈ $4.83 Million |
NT$3.05 Billion ≈ $95.98 Million |
-7.01pp |
| 2019-12-31 | 12.04% | NT$363.61 Million ≈ $11.46 Million |
NT$3.02 Billion ≈ $95.16 Million |
-4.01pp |
| 2018-12-31 | 16.05% | NT$504.99 Million ≈ $15.91 Million |
NT$3.15 Billion ≈ $99.12 Million |
+9.88pp |
| 2017-12-31 | 6.17% | NT$159.49 Million ≈ $5.02 Million |
NT$2.58 Billion ≈ $81.42 Million |
-0.80pp |
| 2016-12-31 | 6.97% | NT$180.59 Million ≈ $5.69 Million |
NT$2.59 Billion ≈ $81.63 Million |
-0.65pp |
| 2015-12-31 | 7.62% | NT$190.51 Million ≈ $6.00 Million |
NT$2.50 Billion ≈ $78.79 Million |
-2.68pp |
| 2014-12-31 | 10.30% | NT$259.44 Million ≈ $8.17 Million |
NT$2.52 Billion ≈ $79.35 Million |
+1.26pp |
| 2013-12-31 | 9.04% | NT$219.61 Million ≈ $6.92 Million |
NT$2.43 Billion ≈ $76.54 Million |
+1.69pp |
| 2012-12-31 | 7.35% | NT$158.44 Million ≈ $4.99 Million |
NT$2.15 Billion ≈ $67.89 Million |
+7.34pp |
| 2011-12-31 | 0.01% | NT$221.00K ≈ $6.96K |
NT$1.95 Billion ≈ $61.37 Million |
-4.37pp |
| 2010-12-31 | 4.39% | NT$71.09 Million ≈ $2.24 Million |
NT$1.62 Billion ≈ $51.07 Million |
+0.75pp |
| 2009-12-31 | 3.64% | NT$60.02 Million ≈ $1.89 Million |
NT$1.65 Billion ≈ $51.98 Million |
-1.78pp |
| 2008-12-31 | 5.42% | NT$95.43 Million ≈ $3.01 Million |
NT$1.76 Billion ≈ $55.48 Million |
+0.00pp |
| 2007-12-31 | 5.41% | NT$87.38 Million ≈ $2.75 Million |
NT$1.61 Billion ≈ $50.84 Million |
-1.95pp |
| 2005-12-31 | 7.36% | NT$100.43 Million ≈ $3.16 Million |
NT$1.36 Billion ≈ $42.99 Million |
-4.50pp |
| 2004-12-31 | 11.86% | NT$144.07 Million ≈ $4.54 Million |
NT$1.22 Billion ≈ $38.28 Million |
-0.50pp |
| 2003-12-31 | 12.36% | NT$148.08 Million ≈ $4.67 Million |
NT$1.20 Billion ≈ $37.76 Million |
-0.89pp |
| 2002-12-31 | 13.24% | NT$80.00 Million ≈ $2.52 Million |
NT$604.01 Million ≈ $19.03 Million |
-- |
About Wellell Inc
Wellell Inc. engages in the manufacture and sale of medical supplies in Europe, the United States, Asia, and internationally. The company offers support surface systems, respiratory therapy devices, and other products. It also provides pressure relief mattress; sleep apnea such as auto-adjusting pressure; sleepwell; compression therapy; and pressure relief seating products. In addition, the compa… Read more